An Open-Label, Multicenter, Phase I/Ib Trial Evaluating the Safety and Pharmacokinetics of Escalating Doses of BTCT4465A as a Single Agent and Combined with Atezolizumab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia

Project: Research

Project Description

NMA HREC Ref Number: HREC/18/SVH/158 (ERM Project ID 46670)
NMA SSA Reference Number: SSA/46670/MonH-2018-153610(v1)
Monash Health Ref: RES-18-0000-679X
StatusActive
Effective start/end date3/12/182/12/23